Daniel Fohrman, MD, finds great reward in giving medical care to Tibetans
Coding Corner Question
November’s Coding Challenge
Coding Corner Answer
November’s Coding Answer
Patient Fact Sheet: Rheumatoid Arthritis
Rheumatoid arthritis (RA), the most common form of inflammatory arthritis, is a chronic disease that causes pain, stiffness, swelling, and limitation in the motion and function of multiple joints. RA is classified as an autoimmune disease, which develops because certain cells of the immune system malfunction and attack healthy joints.
November Is “Heal that Claim” Month
The ACR is joining with the American Medical Association (AMA) in promoting November as “Heal that Claim” month.
“My Office Manager Handles That”
Some rheumatologists in private practice are fortunate enough to have office managers who handle the business side of medicine for them. However, the truth is that it is the physician who is the leader of his or her practice, not the office manager. If nothing else, the physician is the one who manages the office manager.
I Am an Advocate
I have never considered myself to be a political person, much less an “advocate,” which is why I was surprised to become an ARHP advocacy committee member.
What a Bold Vision and Dedication Can Achieve
Over the past two years, you have heard us talking a lot about Within Our Reach: Finding a Cure for Rheumatoid Arthritis, the Research and Education Foundation (REF) campaign to raise and award funds for investigator-initiated research to find a cure for rheumatoid arthritis (RA).
Physician Leaders and the Business of Medicine
In a perfect world, in their work, all people would do what they do best—and only what they do best. Dancers would dance, singers would sing, and physicians and healthcare professionals would spend their time treating patients, teaching, and advancing the science of their profession.
Letters to the Editor
I read with interest Dr. Fox’s perspective in the June issue of The Rheumatologist [TR] regarding ghost writing in medical research. Dr. Fox is all for integrity in research (who isn’t?); nevertheless, he takes to task some of the people (Ross et al and the editors of the Journal of the American Medical Association [JAMA]) who write about the corrupting influence of industry on physicians, including those in academics [JAMA 2008;299(15):1800-1812]. Part of his motivation may be to defend members of ACR who have been involved in the activity of ghostwriting and guest editing. This approach may play well to readers of The Rheumatologist, but it would seem that Dr. Fox should address his concerns to the editors of JAMA. That way, the authors of the article could offer a rebuttal to Dr. Fox’s concerns and assertions, and we all could get closer to the truth about this important issue.
Curing Epidemics at the Strep Lab
A valuable early research education
Enact Change in RA
Future advances could be challenged by structural barriers within the specialty
Looking Ahead to 2009
Moving forward and reflecting back
Experts Debate Merits of Peripheral MRI in Diagnosing RA
New technology comes with a host of pros and cons
The Bone and Joint Decade at the 4/5ths Mark
Missions accomplished?
Cellular Therapy of Autoimmune Disease
Is a novel treatment breakthrough on the horizon?